AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Tarsus Pharmaceuticals, Inc.

$74.85 -$5.92 (-7.33%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$74.20
Day Range
$74.30$76.27
Year Range
$53.89$91.53
Market Cap
3.5B
AVG Volume
977.34K
Trailing/Forward PE
-68.67/73.62
PEG ratio
-1.57
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TARS Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2606.33M
26 Q1535.08M
25 Q4451.36M
25 Q3366.1M
25 Q2295.52M
25 Q1233.67M
24 Q4182.95M
24 Q3129.62M
24 Q283.37M
24 Q142.56M
Net Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TARS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-46.48M
26 Q1-48.27M
25 Q4-66.42M
25 Q3-81.16M
25 Q2-91.99M
25 Q1-104.94M
24 Q4-115.55M
24 Q3-134.34M
24 Q2-150.07M
24 Q1-148.21M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TARS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-48.53M
26 Q1-50.81M
25 Q4-70.97M
25 Q3-87.41M
25 Q2-98.05M
25 Q1-109.17M
24 Q4-120.57M
24 Q3-140.6M
24 Q2-156.37M
24 Q1-155.89M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: TARS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Tarsus Pharmaceuticals, Inc.
TARS
Stockpicker

Video analysis: TARS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TARS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.